A citation-based method for searching scientific literature

Barry H Greenberg. J Card Fail 2002
Times Cited: 8







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
Stephanie Greenstein, Kulsoom Ghias, Nancy L Krett, Steven T Rosen. Clin Cancer Res 2002
185
25

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
M Packer, M R Bristow, J N Cohn, W S Colucci, M B Fowler, E M Gilbert, N H Shusterman. N Engl J Med 1996
25

Effect of carvedilol on survival in severe chronic heart failure.
M Packer, A J Coats, M B Fowler, H A Katus, H Krum, P Mohacsi, J L Rouleau, M Tendera, A Castaigne, E B Roecker,[...]. N Engl J Med 2001
25

A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
C R Crawley, J M Foran, R K Gupta, A Z Rohatiner, K Summers, J Matthews, I N Micallef, J A Radford, S A Johnson, P W Johnson,[...]. Ann Oncol 2000
38
12

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
William S Velasquez, Danika Lew, Thomas M Grogan, C Harris Spiridonidis, Stanley P Balcerzak, Shaker R Dakhil, Thomas P Miller, Keith S Lanier, Robert A Chapman, Richard I Fisher. J Clin Oncol 2003
42
12

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
P McLaughlin, F B Hagemeister, F Swan, F Cabanillas, O Pate, J E Romaguera, M A Rodriguez, J R Redman, M Keating. J Clin Oncol 1994
91
12

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
P Solal-Céligny, P Brice, N Brousse, H Caspard, Y Bastion, C Haïoun, A Bosly, H Tilly, D Bordessoule, C Sebban,[...]. J Clin Oncol 1996
134
12

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
P N Mainwaring, D Cunningham, W Gregory, P Hoskin, B Hancock, A J Norton, K MacLennan, P Smith, G V Hudson, D Linch. Blood 2001
28
12

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
P Sonneveld, M de Ridder, H van der Lelie, K Nieuwenhuis, H Schouten, A Mulder, I van Reijswoud, W Hop, B Lowenberg. J Clin Oncol 1995
220
12

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.
Eva Osby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Stahl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm. Blood 2003
146
12


Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas.
P L Zinzani, M Magagnoli, M Bendandi, F Gherlinzoni, G F Orcioni, C Cellini, V Stefoni, S A Pileri, S Tura. Ann Oncol 2000
37
12

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
P McLaughlin, F B Hagemeister, J E Romaguera, A H Sarris, O Pate, A Younes, F Swan, M Keating, F Cabanillas. J Clin Oncol 1996
238
12

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
John J V McMurray, Jan Ostergren, Karl Swedberg, Christopher B Granger, Peter Held, Eric L Michelson, Bertil Olofsson, Salim Yusuf, Marc A Pfeffer. Lancet 2003
12

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
J Bayliss, M Norell, R Canepa-Anson, G Sutton, P Poole-Wilson. Br Heart J 1987
433
12



Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
12



Diuretic resistance predicts mortality in patients with advanced heart failure.
Gerald W Neuberg, Alan B Miller, Chris M O'Connor, Robert N Belkin, Peter E Carson, Anne B Cropp, David J Frid, Regina G Nye, Milton L Pressler, John H Wertheimer,[...]. Am Heart J 2002
246
12

Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.
F Braunschweig, C Linde, M J Eriksson, C Hofman-Bang, L Rydén. Eur Heart J 2002
60
12



Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.
H A Cooper, D L Dries, C E Davis, Y L Shen, M J Domanski. Circulation 1999
273
12

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Christopher B Granger, John J V McMurray, Salim Yusuf, Peter Held, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Marc A Pfeffer, Karl Swedberg. Lancet 2003
12

Metolazone in treatment of severe refractory congestive cardiac failure.
A Kiyingi, M J Field, C C Pawsey, J Yiannikas, J R Lawrence, W J Arter. Lancet 1990
67
12

Drug therapy and heart failure prevention.
Jennifer V Linseman, Michael R Bristow. Circulation 2003
12
12

Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
J Malcolm O Arnold, Salim Yusuf, James Young, James Mathew, David Johnstone, Alvaro Avezum, Eva Lonn, Janice Pogue, Jackie Bosch. Circulation 2003
159
12

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Marc A Pfeffer, John J V McMurray, Eric J Velazquez, Jean-Lucien Rouleau, Lars Køber, Aldo P Maggioni, Scott D Solomon, Karl Swedberg, Frans Van de Werf, Harvey White,[...]. N Engl J Med 2003
12


Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Salim Yusuf, Stuart Pocock. Lancet 2003
12


Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin. N Engl J Med 2003
12


Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
W S Colucci, M Packer, M R Bristow, E M Gilbert, J N Cohn, M B Fowler, S K Krueger, R Hershberger, B F Uretsky, J A Bowers,[...]. Circulation 1996
500
12

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Stevo Julius, Sverre E Kjeldsen, Michael Weber, Hans R Brunner, Steffan Ekman, Lennart Hansson, Tsushung Hua, John Laragh, Gordon T McInnes, Lada Mitchell,[...]. Lancet 2004
12


A rationale for the use of beta-blockers as standard treatment for heart failure.
M Metra, S Nodari, A D'Aloia, L Bontempi, E Boldi, L D Cas. Am Heart J 2000
47
12



Aldosterone: cardiovascular assault.
Allan D Struthers. Am Heart J 2002
59
12



Obesity and the risk of heart failure.
Satish Kenchaiah, Jane C Evans, Daniel Levy, Peter W F Wilson, Emelia J Benjamin, Martin G Larson, William B Kannel, Ramachandran S Vasan. N Engl J Med 2002
12


Sodium and water balance in chronic congestive heart failure.
R J Cody, A B Covit, G L Schaer, J H Laragh, J E Sealey, J Feldschuh. J Clin Invest 1986
145
12

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Philip A Poole-Wilson, Karl Swedberg, John G F Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J Remme,[...]. Lancet 2003
12

Trends in heart failure incidence and survival in a community-based population.
Véronique L Roger, Susan A Weston, Margaret M Redfield, Jens P Hellermann-Homan, Jill Killian, Barbara P Yawn, Steven J Jacobsen. JAMA 2004
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.